Loading organizations...
Loading organizations...
BB Biotech Ventures: Venture capital firm providing equity financing for clinical development in early-to-mid-stage biotech & healthcare.
Key people at BB Biotech Ventures.
BB Biotech Ventures is a Zurich, Switzerland-based venture capital firm that provides equity financing to private, early-to-mid-stage biotechnology and healthcare companies developing innovative drugs and medical devices. Operating under the advisory of Bellevue Asset Management, the firm is affiliated with the broader BB Biotech publicly listed investment fund, which maintains a market capitalization of approximately 1.56 billion dollars. The organization focuses on the clinical development of novel medications and diagnostics, applying sustainability risk assessments and active management to its life sciences investments. The firm's historical investment portfolio features notable biopharmaceutical enterprises, including Molecular Partners, Radius Health, and Optimer Pharmaceuticals. Recent venture activities by the managing team have transitioned to Bellevue's newer private market funds, such as Pureos Bioventures. Managed by key partners Martin Münchbach and Klaus Breiner, BB Biotech Ventures was officially established in 2004.
BB Biotech Ventures is a healthcare venture-capital vehicle affiliated with the Bellevue/BB Biotech group that focuses on growth and earlier-stage life‑science investments (biotech, therapeutics, medtech) and participates alongside the family of BB/Bellevue investment vehicles in the European and U.S. life‑science ecosystem[2][6].
High‑Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
If you want, I can:
Key people at BB Biotech Ventures.